| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $118M | — | — | — | — |
| Op. Income | $36M | — | — | — | — |
| Gross Margin | 55.7% | — | — | — | — |
| Net Margin | 28.6% | — | — | — | — |
| EPS (Diluted) | $-0.20 | — | — | — | — |
| Free Cash Flow | $64M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $118M |
| Cost of Revenue | $52M |
| GROSS PROFIT | $66M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $30M |
| Other Expenses | $0 |
| Operating Expenses | $30M |
| Cost & Expenses | $82M |
| OPERATING INCOME | $36M |
| Interest Income | $1M |
| Interest Expense | -$10M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $34M |
| Income Tax Expense | -$4M |
| Net Income from Continuing Ops | $37M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $34M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | -$2M |
| D&A | $2M |
| EBIT | $23M |
| EBITDA | $26M |
| EPS | -$0 |
| EPS Diluted | -$0 |
| Item | Amount |
|---|---|
| REVENUE | $118M |
| Cost of Revenue | $52M |
| GROSS PROFIT | $66M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $30M |
| Other Expenses | $0 |
| Operating Expenses | $30M |
| Cost & Expenses | $82M |
| OPERATING INCOME | $36M |
| Interest Income | $1M |
| Interest Expense | -$10M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $34M |
| Income Tax Expense | -$4M |
| Net Income from Continuing Ops | $37M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $34M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | -$2M |
| D&A | $2M |
| EBIT | $23M |
| EBITDA | $26M |
| EPS | -$0 |
| EPS Diluted | -$0 |
| Item | Amount |
|---|---|
| Net Income | $34M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $7M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $398.0K |
| Change in Working Capital | $25M |
| OPERATING CASH FLOW | $69M |
| Capital Expenditure | -$5M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $6M |
| Other Investing Activities | -$272.0K |
| NET CASH FROM INVESTING | $2M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $8M |
| NET CASH FROM FINANCING | -$8M |
| FREE CASH FLOW | $64M |
| Net Change in Cash | $63M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $161M |
| Short-Term Investments | $44M |
| Net Receivables | $44M |
| Inventory | $44M |
| Other Current Assets | $4M |
| TOTAL CURRENT ASSETS | $298M |
| PP&E (Net) | $32M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $180.0K |
| Other Non-Current Assets | $4M |
| TOTAL NON-CURRENT ASSETS | $36M |
| TOTAL ASSETS | $333M |
| Account Payables | $12M |
| Short-Term Debt | $17M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $43M |
| TOTAL CURRENT LIABILITIES | $78M |
| Long-Term Debt | $8M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $170M |
| TOTAL NON-CURRENT LIABILITIES | $178M |
| TOTAL LIABILITIES | $256M |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$8M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $15M |
| TOTAL STOCKHOLDERS' EQUITY | $7M |
| Minority Interest | $71M |
| TOTAL EQUITY | $78M |
| TOTAL LIABILITIES & EQUITY | $333M |
| Total Debt | $26M |
| Net Debt | -$136M |
